ALPHAHELIX MOL.DIAGN. SK1 (4MB) - Cash Flow Conversion Efficiency

Latest as of March 2026: -2.585x

Based on the latest financial reports, ALPHAHELIX MOL.DIAGN. SK1 (4MB) has a cash flow conversion efficiency ratio of -2.585x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.21 Million ≈ $-1.41 Million USD) by net assets (€468.00K ≈ $547.14K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALPHAHELIX MOL.DIAGN. SK1 (4MB) balance sheet quality index to measure how much of total assets are equity-financed.

ALPHAHELIX MOL.DIAGN. SK1 - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how ALPHAHELIX MOL.DIAGN. SK1's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check total reinvestment intensity of ALPHAHELIX MOL.DIAGN. SK1 to assess the company's total reinvestment commitment from operating cash flow.

ALPHAHELIX MOL.DIAGN. SK1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ALPHAHELIX MOL.DIAGN. SK1 ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Future Enterprises Limited NSE:FELDVR	-0.222x
New Energy Metals Corp V:ENRG	0.045x
ARWAY CORP. F:E65	0.458x
Grupo Famsa S.A.B. de C.V MX:GFAMSAA	0.002x
LUNGLIFE AI INC. DL-0001 F:9H4	N/A
Marksmen Energy Inc V:MAH	-0.009x
Schroder European Reit Plc LSE:SERE	0.022x
1Spatial PLC LSE:SPA	0.062x

Annual Cash Flow Conversion Efficiency for ALPHAHELIX MOL.DIAGN. SK1 (2022–2025)

The table below shows the annual cash flow conversion efficiency of ALPHAHELIX MOL.DIAGN. SK1 from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of ALPHAHELIX MOL.DIAGN. SK1.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€637.00K ≈ $744.72K	€820.00K ≈ $958.67K	1.287x	+219.69%
2024-12-31	€4.18 Million ≈ $4.88 Million	€-4.49 Million ≈ $-5.25 Million	-1.076x	-105.67%
2023-12-31	€10.41 Million ≈ $12.18 Million	€-5.45 Million ≈ $-6.37 Million	-0.523x	-462.81%
2022-12-31	€19.89 Million ≈ $23.25 Million	€2.87 Million ≈ $3.35 Million	0.144x	--

About ALPHAHELIX MOL.DIAGN. SK1

F:4MB Germany Diagnostics & Research

Market Cap

$1.12 Million

€957.58K EUR

Market Cap Rank

#30525 Global

#2677 in Germany

Share Price

€0.01

Change (1 day)

+12.00%

52-Week Range

€0.01 - €0.03

All Time High

€0.32